| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |